(VIANEWS) – ELIS (ELIS.PA), NAVAMEDIC (NAVA.OL), TOMRA SYSTEMS (TOM.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ELIS (ELIS.PA)
77.2% sales growth and 5.03% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinal, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is based in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €0.86.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 20.08. Meaning, the purchaser of the share is investing €20.08 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.03%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 3.46B for the twelve trailing months.
Volume
Today’s last reported volume for ELIS is 51677 which is 86.91% below its average volume of 394927.
Moving Average
ELIS’s worth is way higher than its 50-day moving average of €15.45 and way above its 200-day moving average of €13.49.
2. NAVAMEDIC (NAVA.OL)
72.2% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.48.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 88.54. Meaning, the purchaser of the share is investing kr88.54 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr42.50 at 16:20 EST, higher than its 52-week high of kr42.00.
3. TOMRA SYSTEMS (TOM.OL)
12.1% sales growth and 16.76% return on equity
Tomra Systems ASA provides sensor-based solutions for optimal resource productivity worldwide. It operates through three divisions: Collection, Recycling Mining, and Food. The Collection division engages in the development, production, sale, and service of reverse vending machines and related data management systems. This segment is also involved in picking up, transporting, and processing empty beverage containers on behalf of beverage producers/fillers. The Recycling Mining division offers sorting systems for waste and metal material streams; and ore sorting systems for the mining industry. The Food Solutions division provides post-harvest grading and sorting solutions for fresh produce; and sorting and processing technology for the processed food industries. The company was founded in 1972 and is headquartered in Asker, Norway.
Earnings Per Share
As for profitability, TOMRA SYSTEMS has a trailing twelve months EPS of kr6.18.
PE Ratio
TOMRA SYSTEMS has a trailing twelve months price to earnings ratio of 26.46. Meaning, the purchaser of the share is investing kr26.46 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.76%.
Volume
Today’s last reported volume for TOMRA SYSTEMS is 75169 which is 79.2% below its average volume of 361526.
4. MOWI (MOWI.OL)
5.9% sales growth and 23.04% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. The company operates through three segments: Feed, Farming, and Sales and Marketing. It is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. The company offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. It also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. The company offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr16.07.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 11.25. Meaning, the purchaser of the share is investing kr11.25 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.04%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 15.2% and a drop 1.3% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 24, 2023, the estimated forward annual dividend rate is 6.8 and the estimated forward annual dividend yield is 3.96%.
Sales Growth
MOWI’s sales growth is 7.7% for the present quarter and 5.9% for the next.
